Literature DB >> 25773851

Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides.

Guang-Wei Hao1, Yu-Sheng Chen, De-Ming He, Hai-Yu Wang, Guo-Hao Wu, Bo Zhang.   

Abstract

BACKGROUND: Tumors are largely unable to metabolize ketone bodies for energy due to various deficiencies in one or both of the key mitochondrial enzymes, which may provide a rationale for therapeutic strategies that inhibit tumor growth by administration of a ketogenic diet with average protein but low in carbohydrates and high in fat.
MATERIALS AND METHODS: Thirty-six male BALB/C nude mice were injected subcutaneously with tumor cells of the colon cancer cell line HCT116. The animals were then randomly split into three feeding groups and fed either a ketogenic diet rich in omega-3 fatty acids and MCT (MKD group; n=12) or lard only (LKD group; n=12) or a standard diet (SD group; n=12) ad libitum. Experiments were ended upon attainment of the target tumor volume of 600 mm3 to 700 mm3. The three diets were compared for tumor growth and survival time (interval between tumor cell injection and attainment of target tumor volume).
RESULTS: The tumor growth in the MKD and LKD groups was significantly delayed compared to that in the SD group.
CONCLUSIONS: Application of an unrestricted ketogenic diet delayed tumor growth in a mouse xenograft model. Further studies are needed to address the mechanism of this diet intervention and the impact on other tumor-relevant parameters such as invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25773851     DOI: 10.7314/apjcp.2015.16.5.2061

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  23 in total

Review 1.  Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.

Authors:  Rainer J Klement
Journal:  Med Oncol       Date:  2017-06-26       Impact factor: 3.064

Review 2.  Fasting and cancer: molecular mechanisms and clinical application.

Authors:  Alessio Nencioni; Irene Caffa; Salvatore Cortellino; Valter D Longo
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

3.  The Pros and Cons of Low Carbohydrate and Ketogenic Diets in the Prevention and Treatment of Cancer.

Authors:  Ingrid Elisia; Gerald Krystal
Journal:  Front Nutr       Date:  2021-02-25

4.  Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis.

Authors:  Rainer J Klement; Colin E Champ; Christoph Otto; Ulrike Kämmerer
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

Review 5.  Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy.

Authors:  Eric C Woolf; Nelofer Syed; Adrienne C Scheck
Journal:  Front Mol Neurosci       Date:  2016-11-16       Impact factor: 5.639

Review 6.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

Review 7.  Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic Review.

Authors:  Soheila Khodadadi; Nafiseh Sobhani; Somaye Mirshekar; Reza Ghiasvand; Makan Pourmasoumi; Maryam Miraghajani; Somayeh Shahraki Dehsoukhteh
Journal:  Int J Prev Med       Date:  2017-05-25

8.  Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.

Authors:  Thomas N Seyfried; George Yu; Joseph C Maroon; Dominic P D'Agostino
Journal:  Nutr Metab (Lond)       Date:  2017-02-23       Impact factor: 4.169

9.  Cancer Treatment With the Ketogenic Diet: A Systematic Review and Meta-analysis of Animal Studies.

Authors:  Jing Li; Haiyan Zhang; Zhu Dai
Journal:  Front Nutr       Date:  2021-06-09

10.  A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

Authors:  Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Silvia Vidali; Felix Locker; Tricia Rutherford; Maura O'Donnel; Andrea Stöger-Kleiber; Johannes Adalbert Mayr; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.